Giving Guide
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen wins one, loses one in biosimilar battle

By   /   Friday, July 15th, 2016  /   Comments Off on Amgen wins one, loses one in biosimilar battle

    Print       Email
Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Amgen is once again fighting the biosimilar battle on all fronts. Thousand Oaks-based biotech giant Amgen punched a rival drug maker hard when the Food and Drug Administration recommended approval of an Amgen biosimilar but took a hit when the FDA recommended…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Amgen to buy biotech startup TeneoBio

Read More →